Deletion of histone deacetylase 7 in osteoclasts decreases bone mass in mice by interactions with MITF

Melissa Stemig1, Kristina Astelford2, Ann Emery1

  • 1Department of Diagnostic and Biological Sciences, University of Minnesota, Minneapolis, Minnesota, United States of America.

Plos One
|April 16, 2015
PubMed

Insights

Histone deacetylase 7 (HDAC7) normally limits osteoclast formation. Removing HDAC7 in mice boosts osteoclast activity, increasing bone resorption and decreasing bone mass.

Area of Science:

  • Molecular biology
  • Bone biology
  • Cellular regulation

Background:

  • Osteoclasts are key to bone resorption.
  • Transcription factors like MITF control osteoclast differentiation.
  • HDAC7 was previously found to repress MITF activity in vitro.

Purpose of the Study:

  • To investigate the in vivo role of HDAC7 in osteoclast biology.
  • To determine the effect of HDAC7 deletion on bone homeostasis.
  • To elucidate the mechanism of HDAC7-mediated MITF repression.

Main Methods:

  • Conditional deletion of HDAC7 in mouse osteoclasts.
  • Analysis of bone mass and microarchitecture in vivo.
  • Assessment of osteoclast formation and gene expression in vitro.

Main Results:

  • Conditional deletion of HDAC7 in osteoclasts increased osteoclast formation and bone resorption in vivo.
  • HDAC7 knockout mice exhibited reduced bone mass.
  • Expression of MITF target genes was upregulated in HDAC7-deficient osteoclasts.
  • HDAC7's amino-terminus binds MITF and represses its activity, independent of its catalytic domain.

Conclusions:

  • HDAC7 is a critical regulator of MITF activity and bone homeostasis in vivo.
  • Loss of HDAC7 enhances osteoclastogenesis and leads to lower bone mass.
  • HDAC7 functions as a repressor of MITF, but the precise mechanism remains unclear.

Related Concept Videos

Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
4.9K
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
8.7K
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
4.3K